ISMPP Asia-Pacific joins the push for open science in pharma
Oxford PharmaGenesis was in Tokyo to see ‘open science’ take centre stage at the 2019 Asia-Pacific Meeting of ISMPP
Featured
24 January 2024
ACCORD: new guideline to support consistent and complete reporting of consensus methods in biomedical research
Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published in the non-profit open access journal PLOS Medicine.
All
- All
- News
- Articles
- Events
Oxford consultancy receives second royal honour for international trade
Lord Lieutenant leads celebrations at global Oxford-based consultancy
Professional medical writers improve the quality and speed of clinical trial reporting
A systematic review of the impact of professional medical writing support on the quality, ethics and timeliness of clinical trial reporting has been published in Research Integrity and Peer Review.
Oxford PharmaGenesis attends TIPPA East 2019
Both the Oxford PharmaGenesis US (Brian Falcone and Jake Willet) and UK (Eric Southam and Richard White) offices were represented at The International Publication Planning Meeting (TIPPA) East, in Boston on 24–25 June 2019.
Aspiring to new heights: Oxford PharmaGenesis completes the Three Peaks Challenge for charity
In aid of three Oxfordshire-based charities, three employees of HealthScience communications consultancy Oxford PharmaGenesis scaled the three highest peaks in England, Scotland and Wales within 24 hours comprising the Trifecta 3Peaks Challenge.
Disclosure of clinical trial results: are biopharmaceutical industry clinical trial sponsors outperforming their non-industry counterparts?
Who is publishing their clinical trial results? Do biopharmaceutical industry sponsors carry an unfair burden of the blame for the under-reporting of clinical trial results?
